Skip to content

A Clinical Study of Enhancement of fracture healing by Transient Ischemia-reperfusion treatment

A Clinical Study of Enhancement of fracture healing by Transient Ischemia-reperfusion treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17014208
Enrollment
Unknown
Registered
2017-12-28
Start date
2016-07-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limb fracture

Interventions

Trial group:Treatment of repeated ischeia-reperfusion after operation.
Control group:Without RII treatment

Sponsors

Capital Medical University affiliated Beijing Chaoyang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 60 year-old; 2. Diagnosed as Gustilo I/II distal limb fractures; 3. Treated by open reduction or closed reduciton with internal fixation; 4. Have signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosed as pathological fracture; 2. Accompanied by other fractures; 3. Accompanied by metabolic disease or immune disease; 4. Local skin injury; 5. Patients don't cooperate, quit, or default; 6. Patients don't meet the inclusion criterias.

Design outcomes

Primary

MeasureTime frame
X-ray photography;CT scan;

Secondary

MeasureTime frame
Functional scores;Visual Simulation Pain Score;Cytokines;

Countries

China

Contacts

Public Contact+86 Junlin ZHOU

Capital Medical University affiliated Beijing Chaoyang Hospital

fiona4733@126.com010-85231227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026